Counselors in Stoughton, WI Accepting Medicare

8 Counselors found. Showing 1 - 8

Jennifer Betters-bubon, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 127 E Prospect St, Stoughton, WI 53589 Phone: 608-347-1367

Ms. Jean A Daute, MS LPC CSAC ICS MAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 135 W Main St, Suite 207, Stoughton, WI 53589 Phone: 608-873-7838    Fax: 877-674-2177

Carmen Sperle, LPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 3436 County Road A, Stoughton, WI 53589 Phone: 608-215-2018

Veronica M Ellingworth, MS, LPC, SAC, ICS Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Business Park Cir Ste 202, Stoughton, WI 53589 Phone: 608-695-0960

Gabrielle Elise Montana, LPC, SAC-IT Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3185 Deer Point Dr Ste A, Stoughton, WI 53589 Phone: 608-873-7838

Jeani M Oppeneer, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 118 N Madison St, Stoughton, WI 53589 Phone: 608-235-9625

Mr. Joe M Lambert, LPC-IT, SAC-IT Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 135 W Main St, Suite 207, Stoughton, WI 53589 Phone: 608-873-7838    Fax: 877-674-2177

James Benkard, LCSW, CSAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3741 Wi-138, Stoughton, WI 53589 Phone: 608-469-8170    Fax: 608-873-1929

News Archive

Prozac helps learning and memory in people with Huntington's disease

People with Huntington's disease have progressive motor problems, cognitive deficits (dementia) and psychiatric symptoms (the most common is depression) that usually start to appear in mid-life. There is no cure and death usually results within 10 to 20 years of symptom onset, or faster in the childhood-onset form of the disease.

New non-invasive method could improve diagnosis of severe liver disease

A new non-invasive method of predicting the risk of developing a severe form of liver disease could ensure patients receive early and potentially life-saving medical intervention before irreversible damage is done.

Rib-X Pharmaceuticals initiates two separate Phase II clinical trials for antibiotic compound

Rib-X Pharmaceuticals, Inc. has announced the enrolment of the first patients in two separate Phase 2 clinical trials.

Merge Healthcare deploys etrials eDiary 5.0 platform for global urology clinical trial

Merge Healthcare has successfully deployed its etrials eDiary 5.0 platform to conduct a global Phase II urology clinical trial involving 750 patients for one of the largest pharmaceutical companies in the world. Merge was awarded the project because of its eDiary technology, experience in global ePRO (electronic patient reported outcomes) trials and ability to manage the complex logic required by this study. Underway in 22 countries on 3 continents and in 34 languages, the trial also utilizes Merge's new eDiary Inventory Module to track shipping and supply of study devices in real-time.

Tackling ambivalence helps psychosis patients back into work

Teaching motivational interviewing to clinicians providing vocational rehabilitation through individual placement and support improves occupational outcomes for young people with early psychosis, UK researchers report.

Read more Medical News

› Verified 6 days ago